ClearPoint Neuro (CLPT) Total Liabilities (2011 - 2026)

ClearPoint Neuro has disclosed Total Liabilities across 16 years of filings, most recently posting $74.6 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $74.6 million, up 639.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $74.6 million (up 639.61% YoY), and the FY2025 annual result was $69.7 million, up 405.27% from the prior year.
• Total Liabilities came in at $74.6 million for Q1 2026 at ClearPoint Neuro, up from $69.7 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $74.6 million in Q1 2026 to a low of $10.1 million in Q1 2025.
• The 5-year median for Total Liabilities is $19.1 million (2024), against an average of $26.8 million.
• Across the five-year window, Total Liabilities sank 47.08% in 2025 and surged 639.61% in 2026, its largest moves.
• ClearPoint Neuro's Total Liabilities stood at $18.6 million in 2022, then increased by 15.51% to $21.5 million in 2023, then tumbled by 35.78% to $13.8 million in 2024, then soared by 405.27% to $69.7 million in 2025, then gained by 6.95% to $74.6 million in 2026.
• The last three Total Liabilities figures came in at $74.6 million (Q1 2026), $69.7 million (Q4 2025), and $44.5 million (Q3 2025), per Business Quant data.